Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Veeva Systems (VEEV) stock in plain English

Free brief · no signupStart here
VEEVPublished Nov 8, 2026
Veeva Systems Inc
Healthcare · Health Information Services
Sells cloud-based software subscriptions and data services to pharmaceutical and biotechnology companies.
Assets:
Veeva Vault PlatformCore suite handling clinical, quality, and regulatory operations
7,000+ Global EmployeesEngineers, regulatory specialists, and enterprise support staff worldwide
Veeva DQS ScaleCleans trial data across more than 1,000 studies and 1,000,000 subjects
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

80
OPS ScoreOperating finances
Latest quote
-5.15%$262.92
$42.57B
43.3×
$3.46B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 08, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was VEEV. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Veeva Systems (VEEV) do?

Veeva Systems Inc (VEEV) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells cloud-based software subscriptions and data services to pharmaceutical and biotechnology companies. Operates specialized cloud software and data systems built specifically for life sciences regulatory compliance and. It is worth $42.57B on the market and sold $3.46B over the last year.

Market cap
$42.57B
P/E ratio
43.3×
Annual sales
$3.46B
Sector
Healthcare
Industry
Health Information Services
Brief updated
Nov 08, 2026

Brands and businesses behind VEEV

  • Veeva Vault: Cloud platform generating recurring subscription fees by managing clinical trials and regulatory documentation for life sciences firms.
  • Veeva Crossix: Health data platform earning subscription fees by measuring the audience impact of pharmaceutical marketing campaigns.
  • Veeva Compass: Healthcare data product selling longitudinal prescription and patient data feeds to commercial teams.
  • Veeva OpenData: Reference database offering verified customer profiles of healthcare professionals through annual data licenses.

VEEV’s flags, in plain English

Each flag is a number from Veeva Systems’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 08, 2026.

Stupid Cash

Can pay this year's bills 5.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Low debt

Low debt, only 2% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Wide Gross Margin

Gross margin of 74.8% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Priced for Perfection

Priced at 43.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about VEEV

How big is Veeva Systems?

Veeva Systems’ market cap is $42.57B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.46B: what customers paid the company over the last year, before any costs.

What is VEEV’s P/E ratio?

VEEV’s P/E ratio is 43.3×. Investors pay about 43.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with VEEV?

Revenue concentration exists among major global pharmaceutical corporations that face cyclical drug trial pipelines. That is one risk on Veeva Systems’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Veeva Systems’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. VEEV’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card